Detalles de la búsqueda
1.
Optimized Treatment of Interleukin (IL-1)-Mediated Autoinflammatory Diseases: Impact of Disease Activity-Based Treatment Adjustments.
J Clin Med;
13(8)2024 Apr 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-38673592
2.
Non-invasive biomarkers of disease activity and organ damage in ANCA-associated vasculitis: a systematic review.
RMD Open;
10(1)2024 Feb 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-38341193
3.
Long-Term Efficacy and Safety of Canakinumab in Patients With Tumor Necrosis Factor Receptor-Associated Periodic Syndrome: Results From a Phase III Trial.
Arthritis Rheumatol;
76(2): 304-312, 2024 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-37668289
4.
Quantifying hospital-associated costs, and accompanying travel costs and productivity losses, before and after withdrawing tumour necrosis factor-alfa inhibitors in juvenile idiopathic arthritis.
Rheumatology (Oxford);
2023 Dec 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-38123516
5.
Neuroimaging Scoring Tools to Differentiate Inflammatory Central Nervous System Small-Vessel Vasculitis: A Need for Artificial Intelligence/Machine Learning?-A Scoping Review.
Tomography;
9(5): 1811-1828, 2023 10 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-37888736
6.
A decade of progress in juvenile idiopathic athritis treatments and outcomes in Canada: results from ReACCh-Out and the CAPRI registry.
Rheumatology (Oxford);
2023 Oct 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-37851400
7.
Withdrawing biologics in non-systemic JIA: what matters to pediatric rheumatologists?
Pediatr Rheumatol Online J;
21(1): 69, 2023 Jul 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37434157
8.
Paediatric inflammatory multisystem syndrome in Canada: population-based surveillance and role of SARS-CoV-2 linkage.
Pediatr Res;
94(5): 1744-1753, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37277605
9.
What matters most to pediatric rheumatologists in deciding whether to discontinue biologics in a child with juvenile idiopathic arthritis? A best-worst scaling survey.
Clin Rheumatol;
42(8): 2173-2180, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37202606
10.
Distinct phenotypes of multisystem inflammatory syndrome in children: a cohort study.
Pediatr Rheumatol Online J;
21(1): 33, 2023 Apr 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37046304
11.
Developing a Framework of Cost Elements of Socioeconomic Burden of Rare Disease: A Scoping Review.
Pharmacoeconomics;
41(7): 803-818, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37029233
12.
Pharmacological treatment patterns in patients with juvenile idiopathic arthritis in the Netherlands: a real-world data analysis.
Rheumatology (Oxford);
62(SI2): SI170-SI180, 2023 02 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-35583252
13.
Association Between HLA-DPB1 and Antineutrophil Cytoplasmic Antibody-Associated Vasculitis in Children.
Arthritis Rheumatol;
75(6): 1048-1057, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36530128
14.
Resource use and disease severity of children hospitalized for COVID-19 versus multisystem inflammatory syndrome in children (MIS-C) in Canada.
Can Commun Dis Rep;
49(4): 103-112, 2023 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38356877
15.
Tapering of biological treatment in autoinflammatory diseases: a scoping review.
Pediatr Rheumatol Online J;
20(1): 67, 2022 Aug 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-35964053
16.
Use of the Auto-inflammatory Disease Activity Index to monitor disease activity in patients with colchicine-resistant Familial Mediterranean Fever, Mevalonate Kinase Deficiency, and TRAPS treated with canakinumab.
Joint Bone Spine;
89(6): 105448, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35944600
17.
Central nervous system manifestations of monogenic autoinflammatory disorders and the neurotropic features of SARS-CoV-2: Drawing the parallels.
Front Pediatr;
10: 931179, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36034552
18.
Factors associated with care- and health-related quality of life of caregivers of children with juvenile idiopathic arthritis.
Pediatr Rheumatol Online J;
20(1): 51, 2022 Jul 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-35870932
19.
The 2021 EULAR/American College of Rheumatology Points to Consider for Diagnosis, Management and Monitoring of the Interleukin-1 Mediated Autoinflammatory Diseases: Cryopyrin-Associated Periodic Syndromes, Tumour Necrosis Factor Receptor-Associated Periodic Syndrome, Mevalonate Kinase Deficiency, and Deficiency of the Interleukin-1 Receptor Antagonist.
Arthritis Rheumatol;
74(7): 1102-1121, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35621220
20.
The 2021 EULAR/American College of Rheumatology points to consider for diagnosis, management and monitoring of the interleukin-1 mediated autoinflammatory diseases: cryopyrin-associated periodic syndromes, tumour necrosis factor receptor-associated periodic syndrome, mevalonate kinase deficiency, and deficiency of the interleukin-1 receptor antagonist.
Ann Rheum Dis;
81(7): 907-921, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35623638